Management of peritoneal and hepatic metastases from gastrointestinal stromal tumors

被引:26
作者
Patel, SR [1 ]
Benjamin, RS [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Melanoma Sarcoma Med Oncol, Houston, TX 77030 USA
来源
SURGICAL ONCOLOGY-OXFORD | 2000年 / 9卷 / 02期
关键词
D O I
10.1016/S0960-7404(00)00027-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The management of peritoneal and hepatic metastases from gastrointestinal stromal tumors is a challenging clinical problem. Currently available systemic therapeutic agents have very limited activity in this particular disease. Patients with disease confined to a single organ/region are therefore managed either by surgery or regional therapy e.g. intraperitoneal therapy or hepatic arterial chemoembolization, whereas those with multiple sites of involvement should be enrolled on experimental trials of new agents. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:67 / 70
页数:4
相关论文
共 30 条
[1]  
CARNEY JA, 1979, CANCER-AM CANCER SOC, V43, P374
[3]   PRIMARY GASTROINTESTINAL SARCOMAS - ANALYSIS OF PROGNOSTIC VARIABLES [J].
CONLON, KC ;
CASPER, ES ;
BRENNAN, MF .
ANNALS OF SURGICAL ONCOLOGY, 1995, 2 (01) :26-31
[4]  
EDMONSON J, 1999, P AN M AM SOC CLIN, V18, pA541
[5]   Surgical resection and intraperitoneal chemotherapy for recurrent abdominal sarcomas [J].
Eilber, FC ;
Rosen, G ;
Forscher, C ;
Nelson, SD ;
Dorey, FJ ;
Eilber, FR .
ANNALS OF SURGICAL ONCOLOGY, 1999, 6 (07) :645-650
[6]  
Enzinger FM, 1995, SOFT TISSUE TUMORS, P511
[7]  
EVANS HL, 1985, CANCER, V56, P2242, DOI 10.1002/1097-0142(19851101)56:9<2242::AID-CNCR2820560918>3.0.CO
[8]  
2-5
[9]  
HOLTZ D, IN PRESS SARCOMA
[10]  
MACK TM, 1995, CANCER-AM CANCER SOC, V75, P211, DOI 10.1002/1097-0142(19950101)75:1+<211::AID-CNCR2820751309>3.0.CO